Dec. 30 at 2:28 PM
$BSEM BioStem Technologies (OTC: BSEM) reported Q3 2025, generating
$10.5 million in net revenue,
$0.8 million in GAAP net income, and achieving its seventh consecutive quarter of positive adjusted EBITDA, coming in at
$2.7 million.